A joint review by Britain’s food regulators has identified a suite of emerging technologies that could reshape what appears on UK plates by 2035, from meat produced from animal cells to insects as ingredients and digitally fabricated foods. According to the Food Standards Agency’s recent consumer research, a significant minority of Britons are already receptive to these alternatives, with around a third willing to try lab-grown meat and one in four open to eating insects, underscoring why safety and public confidence are central to the regulators’ work.

Cell-cultivated products such as steak, chicken and foie gras are advancing through regulatory channels and industry development, with applications already submitted and more expected in the near term as businesses pursue authorisation. The FSA and Food Standards Scotland have moved to provide safety guidance and a structured sandbox for developers to navigate risk assessment, signalling that cultivated products may reach retail shelves sooner rather than later.

Edible insects are emerging as a pragmatic protein option but carry specific safety considerations. Industry and regulators note that crustacean allergen proteins can be present in some insects, so people with shellfish allergies may be at risk; meanwhile, formal novel-food applications have limited which species may legally remain on the market in Great Britain, leaving only a handful of authorised or applied-for insects in commercial circulation.

Indoor, highly controlled production systems such as vertical farms are already supplying year-round leafy greens and other crops, and other innovations under study include using plants to biosynthesise particular ingredients and gas fermentation that converts captured carbon dioxide into single-cell protein. These approaches are framed as potential tools for improving resilience and reducing the environmental footprint of food production while also raising novel safety and nutritional questions.

Technologies still further from mass rollout include 3D food printing, which researchers and regulators say has promise for personalised textures and nutrient profiles , for example tailoring foods for people with swallowing difficulties , but technical, cost and consumer-acceptance hurdles mean commercial uptake remains limited for now. Industry and FSA reviews note slow printing speeds, quality control challenges and low current consumer awareness as barriers to wider adoption.

Regulators stress that assessments look beyond composition to examine production methods and long-term health implications. Dr Thomas Vincent, deputy director of innovation at the FSA, said: "The food system is always evolving, and as a regulator, we need to keep pace with that and keep pace with the industry so that we can help ensure that new products are safe." He added that evaluations consider hygiene, allergenicity, nutrition and both immediate and chronic risks: "What we do is a really thorough, holistic safety assessment that looks at things like allergenicity, but also at toxicology, at microbial contamination of foods." "It looks at acute risks, so things that might happen once you eat food, but also at chronic risks, so there’s longer-term potential risks, and that includes things like carcinogens, for example," he said.